MedPath

A study comparing the efficacy and safety of two anesthetic drugs etomidate and thiopentone used for electroconvulsive therapy under general anesthesia.

Not Applicable
Conditions
Health Condition 1: F315- Bipolar disorder, current episodedepressed, severe, with psychotic featuresHealth Condition 2: F333- Major depressive disorder, recurrent, severe with psychotic symptomsHealth Condition 3: F339- Major depressive disorder, recurrent, unspecified
Registration Number
CTRI/2024/03/063890
Lead Sponsor
Institute of Neurosciences Kolkata
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

i) Patients between 18 to 65 years of age posted for modified electroconvulsive therapy.

ii) ASA1,2.

iii) Either sex

Exclusion Criteria

i)Patients with a history of adverse reactions to either thiopentone or etomidate,

ii) Patients with a history of cardiovascular, respiratory, neurological disease or electrolyte imbalance

iii)Severe arterial hypertension

iv)ASA 3,4.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath